Abstract:Breast cancer is the most common malignancy in women, and metastasis is the leading cause of death in breast cancer patients. Previous studies have shown that epithelial-mesenchymal transition (EMT) is involved in the metastasis of breast cancer, but the metabolic reprogramming and regulation mechanisms involved in the EMT process are still unclear. In the present study, we successfully constructed an EMT cell model induced by transforming growth factor beta 1 (TGF-beta 1) treatment of MCF-7 cells at different times. The results showed that cell adhesion decreased, cell invasion increased and ATP levels increased in EMT MCF-7 cells treated with TGF-beta 1. Furthermore, the expression of fatty acid synthase (FASN) was decreased, and the expression of key fatty acid beta-oxidation enzymes (CPT1 and CD36) was elevated in treated cells compared to control cells. These results showed that the fatty acid oxidation pathway was enhanced. In addition, the expression of NADH:ubiquinone oxidoreductase subunit B8 (NDUFB8), mitochondrial transcription factor A (TFAM) and cytochrome c oxidase subunit I (COXI) increased, and the mitochondrial DNA copy number and ROS levels were also significantly increased during TGF-beta 1-induced EMT. These results indicated that mitochondrial oxidative phosphorylation (OXPHOS) activity was enhanced during EMT. In addition, we observed that the expression of p-AMPK was increased and ACC (Acetyl-CoA Carboxylase) was decreased during TGF-beta 1-induced EMT in MCF-7 cells. Immunohistochemical analysis of clinical samples revealed high expression of FASN in epithelial cells that had high expression of E-cadherin, while high expression of CPT-1 was observed in mesenchymal cells that had high expression of vimentin. Results of the current study showed a metabolic transition in TGF-beta 1-induced EMT in MCF-7 cells. This transition may regulate fatty acid oxidation and OXPHOS activity in EMT MCF-7 cells through the p-AMPK pathway. These data suggest that a metabolic transition that suppresses lipogenesis and favors energy production is an essential component of TGF-beta 1-induced EMT and metastasis in breast cancer. This study thus provides a new strategy for identifying new therapeutic targets for breast cancer.

TGF-β1 Induces Epithelial-to-mesenchymal Transition Via Inhibiting Mitochondrial Functions in A549 Cells.

TGF-β1-induced Epithelial-to-mesenchymal Transition Depends on Mitochondrial Dysfunction and Biogenesis Impairment in Lung Cancer Cells

Alteration of mitochondrial synthesis and function in epithelial-mesenchymal transition by TGF-β1

Transforming Growth Factor-Β1 Induced Epithelial-Mesenchymal Transition in Hepatic Fibrosis.

Transforming Growth Factor-Β1-induced Epithelial to Mesenchymal Transition Increases Mitochondrial Content in the A549 Non-Small Cell Lung Cancer Cell Line.

Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways

Changes in Mitochondrial Function During EMT Induced by TGFβ-1 in Pancreatic Cancer.

Transforming Growth Factor-Beta 1 Induces Epithelial-To-Mesenchymal Transition In Human Lung Cancer Cells Via Pi3k/Akt And Mek/Erk1/2 Signaling Pathways

TGF‑β1‑induced epithelial‑mesenchymal transition increases fatty acid oxidation and OXPHOS activity via the p‑AMPK pathway in breast cancer cells.

Role of Nuclear Factor Kappa B and Reactive Oxygen Species in the Tumor Necrosis Factor-a-induced Epithelial-Mesenchymal Transition of MCF-7 Cells

Ferritin Heavy Chain-Mediated Iron Homeostasis and Subsequent Increased Reactive Oxygen Species Production Are Essential for Epithelial-Mesenchymal Transition

Redox Regulation in Tumor Cell Epithelial–mesenchymal Transition: Molecular Basis and Therapeutic Strategy

Roles of p38 MAPK and JNK in TGF-β1-induced alveolar epithelial to mesenchymal transition

Mitochondrial dysfunction-induced expression of TGF-β1 pathway promoting epithelial-mesenchymal transition in pancreatic cancer cells after X-ray exposure

TUFM Downregulation Induces Epithelial–mesenchymal Transition and Invasion in Lung Cancer Cells Via a Mechanism Involving AMPK-GSK3β Signaling

Roles of p38 MAPK and JNK in TGF-β1-induced human alveolar epithelial to mesenchymal transition.

Silent Information Regulator 1 Suppresses Epithelial-to-mesenchymal Transition in Lung Cancer Cells Via Its Regulation of Mitochondria Status

Transforming Growth Factor-Β1 Promotes Lung Adenocarcinoma Invasion and Metastasis by Epithelial-to-mesenchymal Transition

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis

Hypoxia-induced Alveolar Epithelial-Mesenchymal Transition Requires Mitochondrial ROS and Hypoxia-Inducible Factor 1.

Inflammatory Cytokines Augments Tgf-Beta 1-Induced Epithelial-Mesenchymal Transition in A549 Cells by Up-Regulating T Beta R-I